Cellular Repair & Recovery
GHK-Cu / KPV
Peptide blend
GHK-Cu and KPV blend
Research context
This preparation combines GHK-Cu, studied in matrix synthesis and gene expression, with KPV, studied in NF-κB pathway modulation. Each is characterised independently in the published literature.
Common assays: Component identity by LC-MS · Purity per component · Metal-binding characterisation
Specification
| Designation | Peptide blend |
|---|---|
| Full name | GHK-Cu and KPV blend |
| Components | GHK-Cu · KPV |
| Formats | 15 mL Advanced Liquid Peptide Spray |
| Solubility | Supplied in metered spray format |
| Storage | Refrigerated 2–8 °C, protected from light |
| Current lot | GK5010N1125 → |
GHK-Cu / KPV COA: certificates of analysis by lot
One lot of GHK-Cu / KPV has a published certificate of analysis from AxisPharm, LLC, an independent laboratory. Each certificate reports the laboratory's results for that lot.
| Lot | Format | Purity (HPLC-UV) | Reported |
|---|---|---|---|
| GK5010N1125 | 50 mg / 10 mg Spray | >99.0% | 2025-11-24 |
Common questions
Does the copper complex interfere with analysis of the second component?
The components are separated chromatographically before quantification and confirmed by their distinct masses, so the measurements do not interfere.
Where can I see the GHK-Cu / KPV certificate of analysis?
Every published GHK-Cu / KPV lot has its own certificate page on this site, listed under "GHK-Cu / KPV COA" above. There is one published lot; the most recent, lot GK5010N1125, was reported on 2025-11-24 at >99.0% purity by HPLC-UV. The certificates are issued by AxisPharm, LLC, an independent laboratory.
Components, blends and pathway
Related compounds
GHK-Cu
Copper tripeptide-1
A naturally occurring copper-binding tripeptide studied in extracellular matrix and gene expression research.
KPV
Lys-Pro-Val tripeptide
The C-terminal tripeptide of α-melanocyte-stimulating hormone, studied in NF-κB signalling.
BPC-157
Body Protection Compound-157
A synthetic pentadecapeptide derived from a gastric juice sequence, studied in migration and angiogenesis models.
TB-500
Thymosin beta-4 fragment
A synthetic fragment corresponding to the actin-binding domain of thymosin beta-4.